Early treatment with infliximabin patients with juvenile idiopathic arthritis

被引:0
|
作者
TV Sleptsova
EI Alexeeva
SI Valieva
TM Bzarova
KB Isayeva
RV Denisova
EV Mitenko
机构
关键词
Public Health; Adverse Event; Arthritis; Infliximab; Early Treatment;
D O I
10.1186/1546-0096-9-S1-P113
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Update on the Treatment of Juvenile Idiopathic Arthritis
    Julia G. Harris
    Elizabeth A. Kessler
    James W. Verbsky
    Current Allergy and Asthma Reports, 2013, 13 : 337 - 346
  • [32] Medical treatment of juvenile idiopathic arthritis
    Hashkes, PJ
    Laxer, RM
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (13): : 1671 - 1684
  • [33] Glucocorticoid treatment in juvenile idiopathic arthritis
    Ezgi Deniz Batu
    Rheumatology International, 2019, 39 : 13 - 27
  • [34] Methotrexate in the treatment of juvenile idiopathic arthritis
    Seeliger, S
    Niehues, T
    Harms, E
    Frosch, M
    Roth, J
    MONATSSCHRIFT KINDERHEILKUNDE, 2002, 150 (04) : 452 - 459
  • [35] Update on the Treatment of Juvenile Idiopathic Arthritis
    Harris, Julia G.
    Kessler, Elizabeth A.
    Verbsky, James W.
    CURRENT ALLERGY AND ASTHMA REPORTS, 2013, 13 (04) : 337 - 346
  • [36] Modern treatment of juvenile idiopathic arthritis
    Horneff, G.
    MONATSSCHRIFT KINDERHEILKUNDE, 2014, 162 (08) : 693 - 700
  • [37] Tocilizumab for the Treatment of Juvenile Idiopathic Arthritis
    Decelle, Kendra
    Horton, Evan R.
    ANNALS OF PHARMACOTHERAPY, 2012, 46 (06) : 822 - 829
  • [38] Infliximab in the treatment of juvenile idiopathic arthritis
    Tzaribachev, N.
    Holzer, U.
    Hansmann, S.
    Schedel, J.
    Kuemmerle-Deschner, J.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2007, 66 : 59 - 59
  • [39] Treatment strategies for juvenile idiopathic arthritis
    Klein, Ariane
    Horneff, Gerd
    EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (18) : 3049 - 3060
  • [40] Advancing the treatment of juvenile idiopathic arthritis
    Murray, Grainne M.
    Sen, Ethan S.
    Ramanan, Athimalaipet, V
    LANCET RHEUMATOLOGY, 2021, 3 (04): : E294 - E305